Identification of Potential Drug Leads from Dendrobium stuartii Through Integrated In Silico, Phytochemical, and Pharmacological Methods
Authors:
- Deni SetiawanDSDeni Setiawan
- Samsul HadiSHSamsul Hadi
- Nur MahdiNMNur Mahdi
- Nurul MardiatiNMNurul Mardiati
- SutomoSUSutomo
- Muhammad Ikhwan RizkiMRMuhammad Ikhwan Rizki
- NormaidahNONormaidah
- Putri Helena Junjung BuihPBPutri Helena Junjung Buih
- Arde Toga NugrahaANArde Toga Nugraha
- Fitri AprilianyFAFitri Apriliany
- Muhammad Rasyid RidhaMRMuhammad Rasyid Ridha
- Moch. Saiful BachriMBMoch. Saiful Bachri
Open Access
- 16 July 2026
- journal article
- research article
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
Abstract
The genus Dendrobium is a rich source of bioactive secondary metabolites, particularly bibenzyl derivatives with substantial pharmacological activities, but Dendrobium stuartii remains an underexplored species. Therefore, this study aimed to investigate the drug discovery potential of D. stuartii through an integrated in silico and experimental method. Four key compounds were prioritized through literature analysis, and the interactions with the epidermal growth factor receptor (EGFR) were evaluated using molecular docking. The chemical profile of the acetone extract was characterized using Liquid Chromatography–High Resolution Mass Spectrometry (LC-HRMS). Additionally, biological activities were assessed through antibacterial, antibiofilm, and anti-inflammatory assays. Batatasin III had the strongest predicted binding affinity toward EGFR, and the LC-HRMS analysis confirmed the presence of bibenzyl derivative 3,4ʹ-dihydroxy-5,5ʹ-dimethoxybibenzyl (gigantol). The extract provided antibacterial activity, specifically against S. aureus and P. acnes , inhibited biofilm formation during the mid-phase, and produced substantial anti-inflammatory activity, as evidenced by significant inhibition of protein denaturation. The results suggested D. stuartii as a promising underexplored source of bioactive compounds with potential applications in anticancer and anti-infective drug development.Keywords
This publication has 77 references indexed in Scilit:
- Synthesis and profiling (in vitro and in silico) of the 6-methoxy/hydroxy substituted 7-acetyl-2-aryl-5-bromobenzofurans for antihyperglycemic, cytotoxic and antioxidant propertiesBioorganic Chemistry, 2025
- Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment OptionsBioDrugs, 2022
- In vitro bioproduction and enhancement of moscatilin from a threatened tropical epiphytic orchid, Dendrobium ovatum (Willd.) Kraenzl3 Biotech, 2021
- Traditional Uses and Pharmacologically Active Constituents of Dendrobium Plants for Dermatological Disorders: A ReviewNatural Products and Bioprospecting, 2021
- HPLC coupled with electrospray ionization multistage MS/MS and TLC analysis of flavones‐C‐glycosides and bibenzyl of Dendrobium hercoglossumJournal of Separation Science, 2020
- Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single InstitutionAdvances in Radiation Oncology, 2019
- A bibenzyl from Dendrobium ellipsophyllum induces apoptosis in human lung cancer cellsJournal of Natural Medicines, 2018
- Cypripedin, a phenanthrenequinone from Dendrobium densiflorum, sensitizes non-small cell lung cancer H460 cells to cisplatin-mediated apoptosisJournal of Natural Medicines, 2018
- Exploring the stability of ligand binding modes to proteins by molecular dynamics simulationsJournal of Computer-Aided Molecular Design, 2017
- A New 9,10-Dihydrophenanthrene Glycoside from Dendrobium primulinumChemistry of Natural Compounds, 2016